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Human T Cell Leukemia Virus Type 1
Oncoprotein Tax Targets the Human Mitotic
Checkpoint Protein MAD1
damage is a consequence of either an inactivation of
the p53 checkpoint (Uittenbogaard et al., 1995) or a
repression of DNA repair functions (Jeang et al., 1990).
Tax-expressing cells have multinuclei and micronuclei,
which contain whole chromosomes, centric chromo-
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and orderly postmitotic nuclear assembly.
Checkpoints ensure the orderly progression of critical
events in the cell cycle (Elledge, 1996; Levine, 1997).Summary
The mitotic (M) spindle checkpoint prevents the onset
of anaphase and subsequent commitment to cellularIn searching for cellular targets of the HTLV-I onco-
division until chromosomes are aligned properly on aprotein Tax, we identified TXBP181, which we charac-
bipolar spindle (Rudner and Murray, 1996). To date, ge-terized as the human homolog of yeast mitotic check-
netic analyses in budding yeast have identified nine pro-point MAD1 protein. Evidence supporting TXBP181 as
teins that are required for preanaphase arrest or delayHsMAD1 includes sequence conservation with yeast
in response to microtubule depolymerization. These areMAD1, hyperphosphorylation during S/G2/M phases
mitotic arrest-defective (MAD) 1 through 3 (Li and Mur-and upontreatment of cells with nocodazole, and bind-
ray, 1991); budding uninhibited by benzimidazole (BUB) 1ing to HsMAD2. HsMAD1 functions as a homodimer.
through 3 (Hoyt et al 1991); monopolar spindle 1 (MPS1;It localizes to the centrosome during metaphase and
Weiss and Winey, 1996); cell division cycle 55 (CDC55),to the spindle midzone and the midbody during ana-
a protein phosphatase 2A subunit (Wang and Burke,phase and telophase. Expression of either Tax or a
1997); and a cyclin-dependent kinase (CDC28; Li andtransdominant-negative TXBP181 results in multinu-
Cai, 1997). The signals that connect moieties in thecleated cells, a phenotype consistent with a loss of
pathway(s) are not well-understood; however, phos-HsMAD1 function. We propose a model of viral trans-
phorylation of MAD1 may provide an important regula-formation in which Tax targets TXBP181, thereby abro-
tory switch (Hardwick and Murray, 1995; Hardwick etgating a mitotic checkpoint.
al., 1996).
Mammalian mitotic checkpoint proteins have begunIntroduction
to be characterized. Recently, a human homolog of
Saccharomyces cerevisiae, ScMAD2, was identifiedHuman T cell leukemia virus type 1 (HTLV-I) is the etio-
(HsMAD2; Li and Benezra, 1996). HsMAD2 localizes to
logical agent for adult T cell leukemia (ATL; reviewed in
kinetochores untethered to the spindle, suggesting a
Uchiyama, 1997). ATL develops in a minority of HTLV-
role in how unattached kinetochores activate an M
I±infected individuals (5% or less) usually more than 20
checkpoint. It has been proposed that MAD2 functions
years after initial exposure to the virus. This pathological
in the context of binding to MAD1 (Rudner and Murray,
course suggests a multistage process of immortaliza-
1996); however, until now HsMAD1 has remained un-
tion and transformation of T lymphocytes.
identified. Unexpectedly, in searching for cellular pro-
HTLV-I encodes a 40 kDa phosphoprotein, Tax. Tax teins that bind Tax, we uncovered a candidate HsMAD1
immortalizes T lymphocytes (Grassmann et al., 1992)
protein that is homologous in sequence with ScMAD1
and transforms rat fibroblasts (Tanaka et al., 1990). Tax
and Schizosaccharomyces pombe SpMAD1.
is also an activator of HTLV-I LTR-directed transcription
Our results document that HsMAD1 functions as a
(Seiki et al., 1986). While the exact events leading to homodimer and that HsMAD1 heterodimerizes with
transformation are incompletely understood, several im- HsMAD2. These findings indicate protein±protein con-
portant cellular processes are dysregulated by Tax (re- tact as a route through which checkpoint components
viewed in Franklin and Nyborg, 1995). Thus, Tax acti- communicate with each other. Viral oncoprotein Tax
vates NF-kB-, SRF-, and CREB/ATF-responsive genes compromises function by contacting HsMAD1 through
and accelerates cell cycle progression (Low et al., 1997). the same domain necessary for homodimerization,
ATL cells are karyotypically abnormal (Poiesz et al., thus leading to the loss of an M checkpoint. This Tax±
1980; Yoshida et al., 1982) and frequently present as HsMAD1 interaction provides a molecular explanation
pleomorphic multinucleated giant cells (Kikuchi et al., for HTLV-I±induced karyotypic abnormalities in ATL
1986; Taguchi et al., 1993). Expression of Tax correlates cells.
with progressive accumulation of damaged DNA in cells
(Majone et al., 1993; Semmes et al., 1996). While the Results
pathways through which this occurs remain to be char-
acterized, there are suggestions that Tax-mediated DNA Identification of TXBP181 as HsMAD1
Expression of Tax in mammalian cells induces DNA
damage (Jeang et al., 1990). This damage is manifested³To whom correspondence should be addressed.
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Figure 2. Functional Domains of TXBP181
TXBP181, TXBP181 mutants, Tax, or HsMAD2 were expressed in
yeast as either Gal4bd or Gal4ad fusion proteins. Protein±protein
interactions were examined by two-hybrid assays. Interactions (1)
or lack of (2) are indicated.
also tallied, then the homology rises to 41.6% (Figure
1B). This conservation is highly significant because re-
latedness is maintained linearly over the entire length
of the polypeptides. Biological relevance of this conser-
vation is further supported by the ScMAD1 sequence.
In reciprocally paired alignments, it was evident that the
relatedness between the two yeast MAD1s does not
significantly exceed that of each to TXBP181 (Figure
1B). Additionally, using the COILS algorithm (Lupas et
al., 1991), all three proteins are predicted to maintain
highly similar coiled-coil domains (data not shown) as
Figure 1. TXBP181 Is a Human Homolog of the Yeast MAD1 Check- previously described for ScMAD1 (Hardwick and Mur-
point Protein ray, 1995).Based on these criteria, we proposeTXBP181
(A) Sequence alignment of full-length TXBP181 and SpMAD1. Dots as a human candidate HsMAD1.
indicate similarities. Vertical bars are identities. Alignment was gen-
erated by the BESTFIT program in the Genetics Computer Group
Interaction of TXBP181 with Taxsoftware package.
and HsMAD2(B) Tabulated sequence comparisons of full-length TXBP181,
SpMAD1, and ScMAD1 proteins. MAD1 is an important component of the spindle assem-
bly checkpoint that detects spindle depolymerization
and other defects (Rudner and Murray, 1996). Possibly,
the aneuploidogenic effects of Tax (Majone et al., 1993;by the formation of multinuclei/micronuclei (Majone et
al., 1993; Semmes et al., 1996). The presentation of mul- Semmes et al., 1996) could be partly explained by its
interaction with HsMAD1. We, thus, analyzed and con-tinucleated cells suggests that a DNA damage check-
point(s) is compromised by Tax. Direct protein±protein firmed Tax±TXBP181 interaction in detail. Previously,
we described 47 single amino acid point mutants of Taxbinding is an obvious route through which Tax could
target host factors. Hence, we searched a human cDNA (Semmes and Jeang, 1992). Wild-type and four repre-
sentative Tax mutants were used to characterize in-library using yeast two-hybrid technology for proteins
that bind Tax. From 1 3 108 gross transformants in a teractions with TXBP181. These results showed that
changes at either residue 29 or 52 (Tax C29-S and TaxHeLa cDNA library, several cDNAs were identified (Jin
et al., 1997). One contained a large, albeit incomplete, H52-Q) abolished binding to TXBP181, while changes
at residues 23 or 320 (Tax C23-S and Tax L320-G) didopen reading frame for a protein provisionally desig-
nated as Tax-binding protein 181 (TXBP181). Rapid am- not (data not shown). In reciprocal assays, we defined
the region spanning amino acids 324 to 498 in TXBP181plification of cDNA ends (RACE) of this clone resulted
in the assembly of a 2626 bp cDNA, which conceptually as a minimal segment for contacting Tax (TXBP181m4;
Figure 2). The yeast two-hybrid readouts further re-translates into a protein of 803 amino acids (Figure 1A;
GenBank U33822). vealed that TXBP181 homodimerizes (Figure 2; column
2). At this level of resolution, the domain for self-associa-TXBP181 was matched against extant protein data-
bases. Unexpectedly, two sequences with the highest tion of TXBP181 coincides with that needed for binding
Tax (TXBP181m4; Figure 2).degree of relatedness were fission yeast SpMAD1 (Fig-
ure 1A; GenBank Z95620) and budding yeast ScMAD1 Yeast MAD1 is proposed to complex with MAD2
(Elledge, 1996; Rudner and Murray, 1996). To our knowl-(Figure 1B; Hardwick and Murray, 1995). Overan approx-
imately 700 amino acid length, 23.9% of all residues in edge, direct experimental evidence documenting this is
not in the literature. Our supposition that TXBP181 isTXBP181 and SpMAD1 are identical. If similarities are
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HsMAD1 prompted an experimental challenge: does
TXBP181 bind HsMAD2? Indeed, this question was ad-
dressed at an early stage of TXBP181 identification. In
1995, when TXBP181 cDNA was first isolated, we failed
to find sequence homologs through database searches.
This led us to use yeast two-hybrids to query further
for cellular proteins that would bind TXBP181 (e.g., the
TXBP181m3 sequence was actually used as bait). Such
search revealed 128 candidate-partners, which segre-
gated into two independent groups. One group con-
tained partial-length TXBP181 cDNAs, consistent with
above results demonstrating that TXBP181 homodimer-
izes. The second group all contained related fragments
of another cDNA (GenBank U31278), which we later
noted to be a sequence independently described by
others as coding for HsMAD2 (Li and Benezra, 1996).
The ªblindedº search that revealed HsMAD2 as a
TXBP181-partner can be illustrated by a reconstruction
experiment. We recloned HsMAD2 cDNA into a two-
hybrid vector and paired this plasmid into yeast with
nine forms of TXBP181 (Figure 2, column 3). Resulting
readouts mapped a HsMAD2-interactive domain be-
Figure 3. Protein±Protein Interaction between TXBP181, Tax, andtween amino acids465 and 584 of TXBP181 (TXBP181m6;
HsMAD2
Figure 2). Thus, separate regions in TXBP181 contact
(A) Tax binds TXBP181. Bacterially produced His-tagged Tax was
Tax and HsMAD2. equilibrated with and then eluted from either immobilized GST (lanes
1±4) or GST±TXBP181 (lanes 5±8). Eluates were resolved by 10%
SDS-PAGE and analyzed by immunoblotting with mouse a-Tax anti-
Coimmunoprecipitation of TXBP181 with Tax body. Tax did not bind GST and was found only in the flow-through
material (FT; lane 1) but not in the salt elutions (0.1, 0.25, 0.5 Mor HsMAD2 from Mammalian Cells
NaCl; lanes 2±4). By contrast, Tax was eluted from GST±TXBP181Direct physical interaction between TXBP181 and Tax or
in the 0.25 and 0.5 M NaCl elutions (lanes 7 and 8). GST±TXBP181HsMAD2 was probed using two additional approaches.
contains amino acids 324-651 of TXBP181.
First, we tested for protein complexes by in vitro affin- (B) Coimmunoprecipitation of TXBP181 and Tax from transfected
ity chromatography using purified glutathione S-trans- cells. HeLa cells were transfected with a Tax-expressing plasmid.
ferase (GST) fusion proteins. Figure 3A shows that Tax Cell extracts were immunoprecipitated using preimmune rabbit se-
rum (preImm; lane 1), rabbit a-181C serum (lane 2), an irrelevantbinds to GST±TXBP181 (lanes 5±8) but not to GST alone
mouse a-LH (lane 4), or mouse a-Tax antibody (lane 5). Western(lanes 1±4). Next, we performed reciprocal coimmuno-
blotting was performed with either mouse a-Tax (lanes 1±3) or rabbitprecipitations using anti-TXBP181 serum (a-181C) fol-
a-181C (lanes 5±6). Tax and TXBP181 are indicated by filled and
lowed by Western blotting with a mouse anti-Tax anti- open arrows, respectively. The migration positions of Tax (lane 3)
body. HeLacells were transfected with a Tax-expression and TXBP181 (lane 6) in nonimmunoprecipitated total lysate are
plasmid, and by varying the sequential uses of antibod- also shown.
(C) HsMAD2 binds to GST±TXBP181 but not GST. HeLa extractsies we verified that Tax coimmunoprecipitated with
were equilibrated with and then eluted from either GST (lanes 1±4)TXBP181 (Figure 3B, compare lane 2 with lane 1) and
or GST±TXBP181 (lanes 5±8) resin. Eluates were resolved by 12%vice versa (Figure 3B, compare lane 5 with lane 4). Con-
SDS-PAGE and reacted with rabbit a-MAD2 serum. From GST,
trol immunoprecipitations performed with either a pre- HsMAD2 was detected in the flow-through only (FT; lane 1). In con-
immune serum (preImm; Figure 3B, lane 1) or a wholly trast, HsMAD2 was eluted from GST±TXBP181 in the 0.25 and 0.5
unrelated mouse antibody to luteinizing hormone (a-LH; M NaCl fractions (lanes 7 and 8). Filled arrow points to HsMAD2.
(D) Coimmunoprecipitation of TXBP181 and HsMAD2. HeLa cellsFigure 3B, lane 4) supported the specificity of Tax±
were either transfectedwith a Gal4bd-TXBP181±expressing plasmidTXBP181 complexes. Indeed, by confocal microscopy,
(lanes 1 and 2) or mock-transfected (lanes 3 and 4). Cell extractsTax expressed inHeLa cells was found to colocalize with
were immunoprecipitated using an irrelevant mouse a-LH (lane 1),
TXBP181 (data not shown), consistent with intracellular mouse a-Gal4 (lane 2), preimmune rabbit serum (preImm; lane 3),
protein±protein contact. or rabbit a-MAD2 serum (lane 4). Immunoprecipitates were probed
HsMAD2±TXBP181 interaction was also assessed. By with either a-MAD2 (lanes 1 and 2) or a-181C (lanes 3 and 4).
HsMAD2 and TXBP181 are indicated by filled and open arrows,affinity chromatography, HsMAD2 was found to bind
respectively. Gal4bd±TXBP181 contains amino acids 324-651 ofGST±TXBP181 (Figure 3C, lanes 5±8) but not GST alone
TXBP181. Ig, rabbit immunoglobulin heavy chain.(lanes 1±4). Direct coimmunoprecipitations verified in-
tracellular TXBP181±HsMAD2 complexes. Two types of
immunoprecipitations were performed. First, HeLa ex-
Cell extract was then immunoprecipitated with either atracts were precipitated with a-MAD2, and the immuno-
mouse antibody to Gal4bd (a-Gal; Figure 3D, lane 2)precipitates were then Western blotted with a-181C.
or an irrelevant antibody, a-LH (Figure 3D, lane 1), fol-This revealed TXBP181 in a complex with HsMAD2 (open
lowed by Western analysis using a-MAD2. This ap-arrow; Figure 3D, compare lane 4 to lane 3). Second,
proach also demonstrated a complex of HsMAD2 withHeLa cells were transfected with a plasmid expressing a
Gal4-binding domain (Gal4bd)±TXBP181 fusion protein. Gal4bd±TXBP181 (filled arrow; Figure 3D).
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Figure 4. Expression and Phosphorylation of
TXBP181 in Cells
(A) Northern blot analysis of TXBP181 in hu-
man cells. Each lane contains approximately
2 mg of polyadenylated RNA.
(B) Expression profiles of TXBP181 protein
throughout the cell cycle. Extracts (z12 mg)
from HeLa cells arrested in indicated phases
(lane 1, 93% cells are in G0; lane 2, 85% in
G1; lane 3, 90% in S; lane 4, 66% in G2; lane
5, 73% in M; lane 6, 62% in G1) were resolved
by 8% SDS-PAGE. Immunoblotting was per-
formed with either a-181C (top) or a-MAD2
(bottom). Hyperphosphorylated and hypo-
phosphorylated TXBP181 are indicated by
open and filled arrows, respectively. A re-
duced exposure of the Western blot that more
clearly illustrates the TXBP181 doublet is
shown as an inset on the right. Cells in lane
7 were treated for 16 hr with 400 ng/ml noco-
dazole.
(C) Phosphorylation of TXBP181 in cells.
HeLa cells were cultured with (lanes 1 and 2)
or without (lanes 3±10) inorganic [32P]ortho-
phosphate (32Pi). Cell extracts were precipi-
tated with preimmune (preImm, lanes 1, 3, 5,
7), a-181C (lanes 2, 4, 6, 8), a-PT/Y (lane 9),
or a-PS/T/Y (lane 10) antibodies. Phosphory-
lated TXBP181 was detected either by auto-
radiography of the gel (lanes 1 and 2) or by
immunoblotting with a-PS/T/Y (lanes 3 and
4), a-PS (lanes 5 and 6), a-PT/Y (lanes 7 and
8), or a-181C antibodies. Hyperphosphory-
lated and hypophosphorylated TXBP181 are
indicated by open and filled arrows, respec-
tively.
(D) Cell cycle±specific expression of TXBP181
in cells. Arrested HeLa cells were fixed with paraformaldehyde and stained with a-181C. Quantitation based on the brightness of TXBP181-
specific fluorescent signal demonstrated a 6.5-fold and a 10.2-fold increase in the S and G2 cells, respectively, when compared to G0 and G1
cells. Bar, 45 mm.
Cell Cycle±Specific Expression and Phosphorylation total labeled extract were immunoprecipitated with ei-
ther preimmune serum or a-181C (Figure 4C, lanes 1of TXBP181
Yeast MAD1 provides some predictions as to the cell and 2). Of several phosphoproteins recovered in the
a-181C immunoprecipitate, two migrated with molecu-cycle±specific expression and posttranslational modifi-
cation(s) of HsMAD1. To address these points, we lar sizes consistent with hyperphosphorylated and hy-
pophosphorylated TXBP181 (open and filled arrows;checked mRNA and protein expression patterns of
TXBP181 in human cells. TXBP181 transcripts in eight Figure 4C, lane 2). Because these immunoprecipitations
of phosphate-labeled proteins with a-181C produceddifferent human cells were assessed by Northern blot-
ting (Figure 4A). An approximately 2.7 kb band was ob- background bands, and because we wished to ascertain
whether phosphate was added to serines, threonines,served in all cells (filled arrow). This mRNA size agrees
with the length of TXBP181 cDNA (2626 nucleotides). or tyrosines, we immunoprecipitated unlabeled cellu-
lar extracts with a-181C (Figure 4C, lanes 4, 6, and 8),Next we asked whether TXBP181 has cell cycle phase±
specific expression/changes consistent with that ex- anti-phosphothreonine mixed with anti-phosphotyro-
sine (a-PT/Y; Figure 4C, lane 9), or a mixture of anti-pected of a MAD1 protein. Using a-181C serum, we
monitored HeLa cells that were either biochemically ar- phosphoserine, anti-phosphothreonine, and anti-phos-
photyrosine (a-PS/T/Y; Figure 4C, lane 10) followed withrested or mechanically selected for G0, G1, S, G2, or M
phase. We found that levels of TXBP181 indeed varied Western blotting using a-PS/T/Y (Figure 4C, lanes 3 and
4), anti-phosphoserine (a-PS; Figure 4C, lanes 5 and 6),throughout the cell cycle: levels were low in G0/G1 and
peaked in late S and G2/M phases (Figure 4B, compare a-PT/Y (Figure 4C, lanes 7 and 8), or a-181C (Figure 4C,
lanes 9 and 10). These variously permuted sequentiallanes 3, 4, and 5 with lanes 1, 2, and 6). Notably, TXBP181
in S and G2/M cells migrated as a doublet. This doublet antibody analyses are consistent with TXBP181 phos-
phorylation being on serine(s) (Figure 4C; compare lanealso appeared when cells were treated with the microtu-
bule-depolymerizing agent, nocodazole (Figure 4B; com- 4 to 3, lane 6 to 5, and lane 10 to 9).
Cell cycle changes of TXBP181 were also studiedpare lane 7 with 6).
The TXBP181 doublet (Figure 4B) is suggestive of using confocal microscopy. Consistent with the Western
analyses (Figure 4B), TXBP181-specific immunofluores-phosphorylation. We analyzed directly for phosphoryla-
tion by labeling biosynthetically with inorganic [32P]or- cence was low in G0 and G1 and increased in S and G2
(Figure 4D). These cell cycle±dependent expression andthophosphate (Figure 4C, lanes 1 and 2). Proteins from
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phosphorylation of TXBP181 conform to previously de-
scribed characteristics of ScMAD1 (Hardwick and Mur-
ray, 1995), further supporting the attribution of TXBP181
as HsMAD1.
Subcellular Locations for TXBP181
To investigate how TXBP181 might behave as a check-
point component, specific antisera were employed to
stain intracellular locales for TXBP181 during the cell
cycle. For comparison, well-defined cellular markers
were costained in parallel. Figure 5 presents costainings
of a-181C and anti-NuMA (group A), a-181C and anti-
a-tubulin (group B), a-181C and anti-kinetochore auto-
antibody (ANA-C; group C), or a-181C and propidium
iodide (group D). These stainings raised several salient
points. First, during interphase, TXBP181 is homoge-
nously distributed in the nucleus in a nucleoli-excluded
pattern (Figure 5B, cell without arrow; Figure 5C). During
this time, TXBP181 colocalizes with ANA-C antiserum±
stained kinetochores (Figure 5C). Second, as the cell
enters prometaphase/metaphase, TXBP181 concentrates
into centrosomes (Figure 5A, panels 1 and 3; Figure 5D,
panels 1 and 2). Third, as the cell commits into anaphase
and later into telophase, TXBP181 is found progressively
in the spindle midzone (Figure 5B, panels 1 and 3; blue
arrow), in the midbody that connects daughter cells (Fig-
ure 5B, panels 1 and 3, white arrow; Figure 5D, panel
3), and in newly formed progeny nuclei (Figure 5D, panel
3). Overall, from the beginning to the end of mitosis,
TXBP181 is seen to move from a diffusely nuclear distri-
bution to the centrosome, to the spindle midzone, and
finally to the midbody. These dynamic changes in pro-
tein localization provide opportunities for pleiotropic
signaling/effector functions during different points of
mitosis.
Loss of TXBP181 Function Resulted
in Multinucleated Cells
Genetic analyses in yeast have documented that MAD2
function is a prerequisite for MAD1 phosphorylation and,
Figure 5. Subcellular Localization of TXBP181 in HeLa Cells
presumably, activation (Hardwick et al., 1996). Above
Cells were fixed either with paraformaldehyde (A±C) or with cold
data (Figures 2, 3C, and 3D) suggest that homodimer- methanol (D) and then stained simultaneously with rabbit a-181C
ization of MAD1 and protein±protein contact between ([A±C], panel 1; [D], panels 1, 2, and 3) and one of the following:
MAD1 and MAD2 might describe physical events impor- mouse anti-NuMA ([A], panel 2), mouse anti-a-tubulin ([B], panel
2), human anti-kinetochore autoantibody (ANA-C; [C], panel 2), ortant for either independent or interactive functions of
propidium iodide (DNA; [D], panels 1', 2' and 3'). Red (TXBP181)the two moieties, leading to a prediction that a TXBP181
and green (NuMA, tubulin, or kinetochore) fluorescent signals weremutant capable of dimerizing with a wild-type counter-
overlaid by computer assistance ([A±C], panel 3). Colocalizations
part but not capable of binding to HsMAD2 might be a are shown in yellow. Cells stained in the absence of a-181C showed
transdominant interfering molecule. Of the nine forms no crossover fluorescent signals from NuMA, tubulin, kinetochore,
of TXBP181 in Figure 2, TXBP181m4 fulfills both criteria. or DNA (data not shown). Samplings of cells in different phases of
the cell cycle are shown: interphase ([B], cell without arrow; [C],Hence, we employed overexpression of TXBP181m4 in
prometaphase; [D], panels 1 and 1'), metaphase ([A]; [D], panels 2a dominant-negative strategy for dissecting TXBP181
and 2', cell with arrow), anaphase ([B], cell with blue arrow), andfunction.
telophase ([B], cell with white arrow; [D], panels 3 and 39). In (A)-
For these studies, an SV40-promoter±driven (C), cells in the same field are shown for panels 1±3. In (D), the same
TXBP181m4-expression plasmid (pSVm4) was con- fields are shown in panels 1 and 1', 2 and 2, and 3 and 3'. Examples
structed. We checked first for overexpression of pSVm4 shown are representative of quadruplicate preparations from five
independent experiments. Bar, 30 mm.using an antibody (a-105) that recognizes both native
TXBP181 and the introduced TXBP181m4 proteins. The
ambient amount of TXBP181 produces a rather uniform the basal fluorescence normally observed for untrans-
cell-to-cell fluorescent intensity (see Figure 6A, panel fected cells (Figure 6A, panel 3). This increased fluo-
1). In cells transfected with pSVm4, a subpopulation rescence is fully consistent with overexpression of
TXBP181m4 in pSVm4-transfected cells.showed enhanced immunofluorescence intensity above
Cell
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Figure 6. Induction of Multinucleated Cells
by Expression of TXBP181m4 or Tax
(A) Examples of TXBP181m4- or Tax-induced
multinucleated cells. HeLa cells were tran-
siently transfected with pM (panels 1 and 2),
pM plus pSVm4 (panels 3±6), or a Tax-
expressing plasmid (panels 7 and 8). Trans-
fected cells were mock-treated (panels 1±4,
7) or treated with nocodazole (200 ng/ml for
20 hr; panels 5, 6, and 8). Cells were fixed and
stained with a-105 (panels 1 and 3), a-Gal4
(panels 2, 4±6), or a-Tax (panels 7 and 8).
Arrows indicate transfected cells. Panels 1
and 2 and panels 3 and 4 are corresponding
fields viewed for either a-105 (1 and 3) or
a-Gal4 (2 and 4) staining. The sensitivity of
image capture was deliberately reduced for
panel 3 compared to 1. Bar, 30 mm.
(B) Graphic quantitation of multinucleated
cells induced by expression of TXBP181m4
or Tax. Cells were transfected with plasmids
expressing the indicated proteins and were
either mock-treated (filled bars) or treated
(open bars) with nocodazole (200 ng/ml for
20 hr). Cells were fixed and stained for nu-
clear morphology with propidium iodide (lane
1), a-Gal4 (lanes 2±4), or a-Tax (lanes 5±10).
Expression of TXBP181 or TXBP181m4 was
also verified by direct stainings. For each de-
termination, 200 positive cells were counted.
Each bar represents the average values from
three independent determinations; values
from each independent determination varied
by less than 20%.
Next, to study how mitosis might be perturbed by What might be the mitotic function defeated by
TXBP181m4? To address this question, we consideredTXBP181m4, we developed an approach that visualizes
the nuclear morphology of transfected cells. Because drugs that affect the M checkpoint. Nocodazole is an
antimicrotubule drugthat disrupts spindle assembly andyeast Gal4bd protein localizes into eukaryotic nuclei and
because it is not normally present in human cells, trans- activates a mitotic checkpoint (Kung et al., 1990). When
the checkpoint is intact, cells with spindle damage arefection of a Gal4bd-expression plasmid (pM) followed by
specific staining with a monoclonal antibody produces blocked from completing mitosis and eventually suc-
cumb to apoptosis (Minn et al., 1996). If TXBP181m4fluorescent nuclear images only from transfectants (for
example, see Figure 6A, panels 2, 4±6). Since calcium interferes with the same checkpoint activated by noco-
dazole, then one would expect the phenotypic conse-phosphate precipitated DNAs are taken together into
cells, nuclei of cells transfected with pSVm4 1 pM can quences induced by the former to be magnified by the
latter (or vice versa). On the other hand, if nocodazolebe visualized by staining solely with a-Gal4bd. Hence,
we transfected cells with either pM alone (Figure 6A, and TXBP181m4 signal into separate and distinct check-
points, then the function(s) inherent to a nocodazolepanels 1 and 2) or pSVm4 1 pM (panels 3±6) and then
stained cells with either a-Gal4bd (panels 2, 4±6) or checkpoint should be unaffected by TXBP181m4. Treat-
ment of cells with nocodazole would not be expecteda-105 (panels 1 and 3). We noted that cells expressing
Gal4bd alone exhibited normal nuclear morphologies to exacerbate a TXBP181m4 phenotype.
In Figure 6B, three sets of cells were transfected with(panel 2) and changed neither in the immunostaining
intensity nor profile for endogenous TXBP181 (panel 1; pM (lane 2), pM 1 pSVTXBP181 (lane 3), or pM 1 pSVm4
(lane 4) and were either treated (open bar) or not treatedcompare staining intensity of arrowed cells with sur-
rounding cells). However, cells cotransfected with pM 1 (filled bar) with nocodazole. Prevalence of multinucle-
ated cells was tabulated based on staining with a-Gal4.pSVm4 did show a new phenotypeÐa significantly
higher prevalence of multinucleated cells (Figure 6A, Results from these assays confirmed that overexpres-
sion of TXBP181m4 increased the ambient level ofpanels 3 and 4; Figure 6B). One interpretation is that
when TXBP181m4 is overexpressed, cells that would multinucleated cells. Nocodazole treatment greatly en-
hanced this change (Figure 6B, lane 4). These findingsotherwise have been blocked from completing mitosis
now escape this block, thus becoming multinucleated. suggest that TXBP181m4 and nocodazole converge at
the same mitotic checkpoint, and they are consistentThis finding suggests that TXBP181m4 compels a domi-
nant-negative effect, which subverts a mitotic surveil- with TXBP181m4 behaving as a dominant-negative in-
hibitor of HsMAD1.lance function of wild-type TXBP181.
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Tax Targets a TXBP181-Mediated Mitotic
Checkpoint Function
Expression of HTLV-I Tax induces potently multinucleated
and micronucleated cells (Majone et al., 1993; Semmes
et al., 1996). Examples of Tax-induced multinucleated
cells are shown in Figure 6A (panel 7). To understand
better this phenotype, we assayed the activities of four
Tax point-mutants. These mutants, TaxC23-S, TaxC29-S,
TaxH52-Q, and TaxL320-G, have been characterized
previously for transcriptional activities (Semmes and
Jeang, 1992). Of the four, TaxC23-S was found to be
active, while the other three were inert. The four mutants
were also defined for ability to bind TXBP181 with find-
ings that TaxC23-S and TaxL320-G bound TXBP181,
while TaxC29-S and TaxH52-Q did not (data not shown).
In Figure 6B, we assessed the ability of each mutant to
induce multinuclei. TaxC23-S and TaxL320-G, as well
as wild-type Tax protein, induced multinucleated cells
efficiently, while Tax C29-S and Tax H52-Q were quite
inactive (lanes 5±9). The multinuclei-inducing pattern is
discordant from the transcriptional profiles of the same
mutants, as transcriptionally defective TaxL320-G was
highly active for multinuclei induction. On the other hand,
the capacity of individual mutants to induce multinuclei
correlated well with ability to bind TXBP181. Thus, Figure 7. Reduced Amounts of TXBP181 Protein upon Expression
of TaxTXBP181-binding mutants (TaxC23-S and TaxL320-G)
Extracts (15 mg) from Jurkat (lane 1), C81 (lane 2), uninduced JPX9were multinuclei-inducing, while nonbinding mutants
(lane 3), Cd21-induced JPX9 (lane 4), and Cd21-induced JPX9m (lane(TaxC29-S and TaxH52-Q) were not.
5) cells were probed for expression of Tax (A), TXBP181 (B), andTXBP181 binding by Tax or by TXBP181m4 inhibits
HsMAD2 (C) proteins by Western blotting. Induction of Tax was by
homodimerization (Figure 2). In our assays, expression adding 25 mM CdSO4 to the culture for 3 hr. Note reduced amount
of Tax or TXBP181m4 induces multinuclei. This is sug- of TXBP181 in C81 (lane 2) and JPX9 1 Cd (lane 4) cells. This
gestive of a shared mechanism: the prevention of reduction correlates with the expression of wild-type Tax protein in
both cell samples. Total RNAs from the same series of cells wereTXBP181 homodimer formation inactivates a mitotic
also prepared and the expression of TXBP181 mRNA was assessedsurveillance function. The fact that the multinuclei-
by quantitative-competitive RT-PCR using specific primers (D). Theinducing capacity of Tax and of TXBP181m4 responds
target DNA is 180 bp. Five nanograms of an engineered competitor
in the same synergistic fashion to nocodazole treatment DNA MIMIC (210 bp) containing identical primer-binding sites was
(Figure 6A, panels 5, 6, and 8; Figure 6B, lanes 4 and 5) added as an internal control.
provides further evidence that both share a common
mechanism through TXBP181.
The link between Tax, TXBP181, and multinuclei is
amounts of TXBP181 (Figure 7B, lanes 2 and 4), while
strengthenedby the observation that Tax-induced multi-
cells that either do not express Tax (Jurkat, JPX9; lanes
nuclei are prevented by overexpression of exogenous
1 and 3) or express a mutant Tax (JPX9m 1 Cd; lane 5)
TXBP181. Thus, the 47% of multinucleated cells that
had high amounts of TXBP181. On the other hand, all
result from Tax expression (Figure 6B, lane 5) was re-
cells, regardless of Tax expression, maintained similar
duced to 15%when a TXBP181-expressing plasmidwas
amounts of HsMAD2 (Figure 7C). Pulse-chase analysis
cointroduced (lane 10). This suggests that in HTLV-I±
of cellular [35S]-labeled TXBP181 was performed (data
infected cells the relative ratio of Tax to TXBP181 dic-
not shown); the half-life of TXBP181 in Tax-expressing
tates checkpoint competence.
C81 cells (2.3 hr) was found to be significantly reduced
To assess the levels of TXBP181 and Tax in ATL cells,
compared to that inJurkat cells (6.1 hr). RT-PCRanalysis
we examined HTLV-I transformed human T cell line (C81)
of TXBP181 mRNA indicated that the Tax-mediated re-and two Jurkat-derived T cell lines (JPX9 and JPX9m)
duction of TXBP181 did not occur at the step of tran-that have been engineered to express either a wild-type
scription (Figure 7D). Thus, these findings suggest thator a mutant Tax protein upon treatment with cadmium
in ATL cells a mitotic checkpoint is lost as a conse-(Cd). An abundance of Tax is expressed in C81 (Salahud-
quence of Tax-induced reduction of HsMAD1 dimeriza-din et al., 1983) and in JPX9 cells treatedwith Cd (JPX9 1
tion and stability.Cd; Nagata et al., 1989), and a defective Tax mutant is
highly expressed inJPX9m 1 Cd (K. Sugamura, personal
Discussioncommunication). Jurkat and JPX9 cells (not treated with
Cd) do not express Tax. Each of these cells was checked
TXBP181 Is a Human Homolog of Yeast MAD1directly by Western blotting using anti-Tax to verify for
Several lines of evidence suggest that HTLV-I Tax-bind-expected Tax expression (Figure 7A). When the samples
ing protein, TXBP181, is the human homolog of theyeastwere reprobed with either a-181C or a-MAD2, we noted
that cells that express functional Tax had reduced mitotic checkpoint proteins, ScMAD1 and SpMAD1.
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First, the sequence of TXBP181 is virtually as well con- 1996), the MAD1±MAD2 interaction might be physically
described by a MAD1±MAD2 heterodimer. Whether theserved with SpMAD1 as SpMAD1 is conserved with
ScMAD1 (Figure 1). Structurally, all three proteins main- relevant interaction is at the centrosome and how this
might relate to either a spindle checkpoint function ortain very similar coiled-coil motifs (data not shown). Sec-
ond, a defining characteristic of MAD1 is that it binds a later mitotic function remain to be elucidated.
HsMAD1 and HsMAD2 add to the growing list of mi-MAD2 (Elledge, 1996; Rudner and Murray, 1996). Indeed,
TXBP181 binds HsMAD2 (Figures 2 and 3) in agreement totic factors that are found at the centrosome. These
include ScMPS1 (Hardwick et al., 1996; Weiss and Winey,with its identification as HsMAD1. Third, abrogation of
TXBP181 function produces an aberrant mitotic pheno- 1996), p53 (Blair and Blair, 1988), CDC2/CDK1 (Pock-
winse et al., 1997), CDC16 and CDC27 (Tugendreich ettype that is consistent with a hsmad1 genotype. Thus,
expression of a transdominant-negative TXBP181 mu- al., 1995),and NuMA (Compton et al., 1992). Additionally,
it has been suggested that a p53-mitotic regulatory func-tant induced multinuclei in cells (Figure 6) in a manner
that augments the multinuclei-inducing capacity of no- tion might be correlated with its activity in modulating
centrosome duplication (Fukasawa et al., 1996; Agarwalcodazole. This suggests that a loss of TXBP181 function
results in a premature escape from a mitotic block, et al., 1998). Indeed, the centrosome and the spindle
midzone have been further found to be important forwhich is not necessarily linked to cytokinesis. In late
mitosis, TXBP181 relocates to the midbody that links cytokinesis (Oegema and Mitchison, 1997). Evidence
suggests that signals from the spindle midzone andtwo daughter cells, suggesting that it might serve addi-
tional cell-division functions (see below). midbody and the continuous interaction between mid-
zone microtubule bundles and the cortex dictate suc-Another finding shared between ScMAD1 and TXBP181
is that both become hyperphosphorylated in late S cessful cytokinesis incultured mammalian cells (Glotzer,
1997). Our demonstration that TXBP181 moves from thethrough M phases (Figure 4). This hyperphosphorylation
is also triggered by mitotic spindle damage (Figure 4). kinetochore to the centrosome to the spindle midzone
and finally to the midbody suggests that this proteinA critical component of the mitotic checkpoint is a phos-
phoepitope recognized by a 3F3/2 antibody (Campbell might transduce signals that regulate the induction of
cleavage furrow and link mitosis with cytokinesis. Thisand Gorbsky, 1995). The characterization of ScMAD1
(Hardwick and Murray, 1995) and TXBP181 (Figure 4) is consistent with findings of multinucleated cells when
TXBP181 function was lost (Figure 6).as phosphoproteins raises the possibility that these pro-
teins may contain thekinetochore-associated 3F3/2 epi-
tope. Indeed, during interphase, TXBP181 is found at
Checkpoints and Viral Transformationthe kinetochore (Figure 5); however, preliminary ex-
of the Cellperiments indicate that 3F3/2 reacts poorly with anti-
Failure in cell cycle control is well-recognized as contrib-TXBP181 immunoprecipitates and vice versa (D.-Y. J.,
uting to genetic instability, which is a hallmark of can-et al., unpublished data). Whether this is explained
cers. Experiments in budding yeast have shown thatby a transient and rare ªmaskedº phosphoepitope in
the disruption of genes required for spindle checkpointTXBP181 being recognized by 3F3/2 but is otherwise
dramatically increases the rate of chromosome loss (Lidifficult to detect, or whether the 3F3/2 kinetochore-
and Murray, 1991; Pangilinan and Spencer, 1996). Plau-effector is wholly distinct from MAD1 remains to be
sibly, in humans, interference of mitotic checkpointconfirmed.
function leads to karyotypic abnormalities, which de-
pending on circumstances can be both a cause and
an effect of cellular transformation. The interaction ofLocalization of TXBP181 to the Centrosome
and Midbody TXBP181 and Tax oncoprotein presumably describes
a part of virally initiated events that lead to cell-cycleAt various times during mitosis, TXBP181 is localized
to the kinetochore, the centrosome, and the midbody. dysregulation (Low et al., 1997), DNA damage (Jeang et
al., 1990), and cellular transformation in ATL.Although tension at the (unattached) kinetochore (Nick-
las, 1997) represents an early signal for the spindle We have shown that Tax has aneuploidogenic and
clastogenic effects and induces multinuclei in mamma-checkpoint, steps subsequent to this are poorly charac-
terized. Plausibly, signals from other subcellular locales lian cells. Here, a functional target for Tax was defined
as the HsMAD1 protein. Previously, it was understoodmight contribute to later mitotic events. Thus, while both
TXBP181 and HsMAD2 localize to kinetochores, our evi- that Tax could influence via p53 the G1 to S phase transi-
tion and the DNA-damage sentinel at this juncture (Uit-dence indicates that it is not at this locale that the two
proteins interact. Instead, we find that the two proteins tenbogaard et al., 1995); however, it was unclear how
to account for aneuploidy, polyploidy, and the inductionappear at kinetochores during different times of the cell
cycle. In particular, TXBP181 is found at kinetochores of kinetochore-containing micronuclei in Tax-express-
ing cells. Our finding that Tax compromises an M-check-during interphase, while HsMAD2 appears there during
prometaphase (Li and Benezra, 1996). During meta- point protein (HsMAD1) provides a reasonable explana-
tion for the latter phenomena.phase both TXBP181 (Figure 5) and HsMAD2 (data not
shown) congress at the centrosome, suggesting that Induction of multinuclei by Tax places this HTLV-I
gene into a functional class of viral oncogenes sharedwhile each might have individual checkpoint roles at the
kinetochore, the interactive function(s) of the two may by Mos, SV40 Tag, and EBV LMP-1 (reviewed in Laird
and Shalloway, 1997). Thus, expression of Mos (Fuka-occur at the centrosome. Based on evidence presented
here and suggested elsewhere (Rudner and Murray, sawa and Vande Woude, 1997), LMP-1 (Knecht et al.,
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(Tropix). For metabolic labeling of proteins, cells were cultured for1996), and SV40 Tag (Chang et al., 1997) is associated
2.5 hr in 1 mCi/ml [32P]orthophosphate (Amersham) or 250 mCi/mlwith multinucleated cells. The mechanism through which
[35S]methionine/cysteine (NEN). Rabbit anti-TXBP181 (a-181C) wasthese oncoproteins interfere with mitosis is not known,
raised against a keyhole limpet hemocyanin-conjugated TXBP181
but one hypothesis is that they interfere with a p53- C-terminal peptide (amino acids 785-803). Monoclonal anti-Gal4bd
dependent mitotic checkpoint (Cross et al., 1995). The (clone RK5C1) was from Santa-Cruz. Monoclonal antibody against
human luteinizing hormone (a-LH) was from Boehringer Mannheim.findings that abrogation of MmBUB1 (Taylor and McKeon,
Monoclonal a-PS/T/Y was from CLONTECH; polyclonal a-PS was1997) and/or HsMAD1 (this report) function also re-
from Zymed; and a-PT/Y was a mixture of monoclonal antibodiessults in multinucleated cells, and the demonstration
from Sigma, Zymed, and Santa-Cruz (clones PT-5H5, PTR-8, andthat Tax directly binds HsMAD1 raise the possibility that
PY-20).
M-checkpoint proteins might be generally targeted by
many viral oncoproteins. Confocal Microscopy
One intriguing thought that emerges from the identifi- Microscopy was performed as described (Semmes and Jeang,
cation of TXBP181 as HsMAD1 is a potential mechanis- 1996). Cells were fixed either with 4% paraformaldehyde (pH 7.4)
in PBS for 15 min at room temperature or with absolute methanoltic link between disparate cell-cycle checkpoints. In a
for 10 min at -208C. Costaining of TXBP181 with nuclear DNA wasªblindedº assay of all cellular transcripts that are in-
with fluorescein-conjugated second antibody and propidium iodide.duced by p53, TXBP181 was found to be 1 of only 13
Brightness of fluorescence was quantitated with Zeiss LSM soft-(out of a cellular pool of 7202 transcripts) mRNAs that
ware. Monoclonal anti-NuMA (clones 204-41 and 107-7) was from
are induced 10-fold or more by p53 (Polyak et al., 1997). MatriTech. Monoclonal anti-a-tubulin (clone B-5-1-2) and human
The identification of TXBP181 as HsMAD1 suggests that polyclonal anti-kinetochore autoantibody (ANA-C) were from Sigma.
Rabbit polyclonal anti-TXBP181 (a-105) was raised to a GST±while p21 (El-Deiry et al., 1993) is a direct transcriptional
TXBP181m5 (amino acids 324-411) fusion. Wild-type and mutanttransponder of p53 at G1 to S, HsMAD1 might be an
Tax have been described elsewhere (Semmes and Jeang, 1992,analogous transponder for the p53-dependent mitotic
1995, 1996). pM was from CLONTECH. TXBP181- and TXBP181m4-checkpoint (Cross et al., 1995). If so, p53 then has a
expressing plasmids were derivatives of pSV-b (Promega).
true mitotic checkpoint function, and it does not simply
serve to prevent cells that have failed M phase from RNA Analysis
reinitiating DNA replication (Minn et al., 1996). Our find- Human multiple tissue Northern blot (CLONTECH) was probed with
ings plausibly explain how oncoproteins might simulta- a 1.1 kb 32P-labeled 59 fragment of TXBP181 cDNA. RNAs were
isolated using RNAzol (Tel-Test). Quantitative-competitive RT-PCRneously defeat both a G1/S and an M checkpoint by
of TXBP181 mRNA was performed using PCR MIMIC strategytargeting through a single factor, p53.
(CLONTECH). TXBP181-specific primers are as follows: 59- CAGGG
CTCCAA CTTGCAGA -39 and 59- ACCTG GGGCCGAGGTAGAA-39.
Experimental Procedures
Cell SynchronizationYeast Two-Hybrid Assay
HeLa cells in G0 were by serum starvation. HeLa G1 cells were byYeast two-hybrid screening was performed in CG-1945 according
lovastatin treatment (Keyomarsi et al., 1991). HeLa G1/S cells wereto the manufacturer's protocol (CLONTECH). CG-1945 was trans-
by double thymidine block (i.e., two 16 hr incubations in 2.5 mMformed with pGADT9/Tax (Jin and Jeang, 1997; Jin et al., 1997) or
thymidine, with an 8 hr release). Cells enriched in S phase werepGADT9/TXBP181m3 and screened with a HeLa S3 cDNA expression
harvested 4 hr after release from the second block. Cells harvestedlibrary constructed in plasmid pGADGH. Ten millimolar 3-amino-
8 hr after this release were further enriched for G2 population bytriazole was added to the medium to inhibit His3p expression acti-
rinsing extensively to remove mitotic cells. M phase cells were me-vated by Gal4bd-Tax alone (Jin and Jeang, 1997). We screened on
chanically shaken off from log-phase cultures and collected. Tofifty 150 mm dishes 1 3 108 gross transformants representative of
obtain cells in early G1, the shaken-off cells were added into fresh106 independent clones.
medium for an additional 3 hr. Synchronous mitotic cells were also
obtained by incubating for 16 hr in medium containing 400 ng/mlProtein Affinity Chromatography
nocodazole. Cell synchrony was monitored by immunofluorescentGST, GST±TXBP181, and His-tagged Tax were purified according
staining with anti-Ki-67 and anti-bromodeoxyuridine antibodiesto manufacturers' protocols (Pharmacia and Invitrogen). His-Tax
(Boehringer Mannheim; Keyomarsi et al., 1991) and by phase-con-containing resin was washed with buffer A (50 mM sodium phos-
trast microscopy.phate [pH 8.0]), 300 mM NaCl, 0.5 mM b-mercaptoethanol, and 1
mM PMSF) containing 40 mM imidazole. His-Tax was eluted with
buffer A containing 300 mM imidazole. GST and GST±TXBP181 Acknowledgments
resins were equilibrated with buffer B (20 mM HEPES±KOH [pH 7.9],
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